Prudential Financial
ADPT icon

Prudential Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Prudential Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Sell
145,800
-213,300
-59% -$3.27M ﹤0.01% 1219
2026
Q1 		$4.98M Sell
359,100
-88,980
-20% -$1.42M 0.01% 920
2025
Q4 		$7.28M Buy
448,080
+137,955
+44% +$2.25M 0.01% 751
2025
Q3 		$4.64M Sell
310,125
-103,730
-25% -$1.26M 0.01% 981
2025
Q2 		$4.82M Sell
413,855
-224,130
-35% -$2.04M 0.01% 921
2025
Q1 		$4.74M Buy
637,985
+156,020
+32% +$1.2M 0.01% 861
2024
Q4 		$2.89M Buy
481,965
+467,751
+3,291% +$2.58M ﹤0.01% 1121
2024
Q3 		$72.8K Buy
14,214
+2,549
+22% +$11.1K ﹤0.01% 2608
2024
Q2 		$42.2K Buy
+11,665
New +$37K ﹤0.01% 2627
2023
Q4 		– Sell
-283,542
Closed -$1.55M – 2645
2023
Q3 		$1.55M Sell
283,542
-234,925
-45% -$1.55M ﹤0.01% 1526
2023
Q2 		$3.48M Sell
518,467
-247,450
-32% -$1.84M 0.01% 1094
2023
Q1 		$6.76M Buy
765,917
+601,150
+365% +$5.3M 0.01% 771
2022
Q4 		$1.26M Buy
164,767
+142,800
+650% +$1.11M ﹤0.01% 1588
2022
Q3 		$150K Buy
+21,967
New +$207K ﹤0.01% 2486
2022
Q1 		– Sell
-6,608
Closed -$243K – 2605
2021
Q4 		$243K Sell
6,608
-91
-1% -$2.79K ﹤0.01% 2478
2021
Q3 		$267K Buy
6,699
+2
+0% +$72 ﹤0.01% 2369
2021
Q2 		$273K Buy
6,697
+495
+8% +$19.2K ﹤0.01% 2347
2021
Q1 		$250K Buy
6,202
+231
+4% +$12.5K ﹤0.01% 2336
2020
Q4 		$353K Buy
+5,971
New +$308K ﹤0.01% 2196

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prudential Financial's ADPT Position: Q2 2026 in Review

Prudential Financial reduced its Adaptive Biotechnologies (ADPT) stake by 59% in Q2 2026, selling an estimated $3.27M and leaving 145,800 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Prudential Financial first reported a position in ADPT in Q4 2020 and has held it in 19 quarters since. The position peaked at $7.28M in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Prudential Financial held 145,800 shares of Adaptive Biotechnologies worth $3.13M as of Q2 2026.
  • Prudential Financial sold 213,300 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.27M.
  • Adaptive Biotechnologies made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1219 holding.
  • Prudential Financial first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 19 quarters since.
  • Prudential Financial's Adaptive Biotechnologies position peaked at $7.28M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.